Medpace Holdings Operating Expenses 2014-2024 | MEDP

Medpace Holdings annual/quarterly operating expenses history and growth rate from 2014 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Medpace Holdings operating expenses for the quarter ending September 30, 2024 were $0.421B, a 3.3% increase year-over-year.
  • Medpace Holdings operating expenses for the twelve months ending September 30, 2024 were $1.662B, a 14.18% increase year-over-year.
  • Medpace Holdings annual operating expenses for 2023 were $1.549B, a 31.13% increase from 2022.
  • Medpace Holdings annual operating expenses for 2022 were $1.181B, a 25.17% increase from 2021.
  • Medpace Holdings annual operating expenses for 2021 were $0.944B, a 24.36% increase from 2020.
Medpace Holdings Annual Operating Expenses
(Millions of US $)
2023 $1,549
2022 $1,181
2021 $944
2020 $759
2019 $734
2018 $604
2017 $371
2016 $369
2015 $338
2014 $322
2013 $214
Medpace Holdings Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $421
2024-06-30 $423
2024-03-31 $407
2023-12-31 $411
2023-09-30 $408
2023-06-30 $382
2023-03-31 $348
2022-12-31 $318
2022-09-30 $306
2022-06-30 $291
2022-03-31 $267
2021-12-31 $254
2021-09-30 $242
2021-06-30 $236
2021-03-31 $212
2020-12-31 $205
2020-09-30 $184
2020-06-30 $175
2020-03-31 $195
2019-12-31 $194
2019-09-30 $186
2019-06-30 $179
2019-03-31 $175
2018-12-31 $161
2018-09-30 $152
2018-06-30 $147
2018-03-31 $143
2017-12-31 $97
2017-09-30 $93
2017-06-30 $90
2017-03-31 $91
2016-12-31 $95
2016-09-30 $95
2016-06-30 $92
2016-03-31 $87
2015-12-31
2015-09-30 $85
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $9.789B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00